Department of Biotechnology hosts webinar on biomanufacturing of enzymes
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Divestment is part of BASF’s strategic portfolio optimization
Launch of new product range aligns with strategy to diversify into emerging applications with high growth potential
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Subscribe To Our Newsletter & Stay Updated